JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
Allient
ALNT
$1.99B
| $941K | ﹤0.01% |
41,048
+9,812
| +31% | +$271K |
2017 Q4
5 quarters
|
|
|
CVA
3677
DELISTED
Covanta Holding Corporation
CVA
| $941K | ﹤0.01% |
54,372
-500
| -0.9% | -$8.17K |
2013 Q2
23 quarters
|
|
3678
Century Aluminum
CENX
$3.68B
| $937K | ﹤0.01% |
105,578
-376,964
| -78% | -$3.26M |
2013 Q2
23 quarters
|
|
|
NRE
3679
DELISTED
NorthStar Realty Europe Corp.
NRE
| $934K | ﹤0.01% |
53,791
-33,342
| -38% | -$566K |
2015 Q4
13 quarters
|
|
3680
iShares Core Conservative Allocation ETF
AOK
$822M
| $932K | ﹤0.01% |
26,988
-4,867
| -15% | -$164K |
2015 Q3
14 quarters
|
|
|
RYZ
3681
Ryerson Holding Corp
RYZ
$1.38B
| $932K | ﹤0.01% |
108,885
-382
| -0.3% | -$2.96K |
2016 Q1
12 quarters
|
|
|
SGMO
3682
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $931K | ﹤0.01% |
97,651
-5,785
| -6% | -$59.1K |
2016 Q4
9 quarters
|
|
3683
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$61.4M
| $930K | ﹤0.01% |
25,228
-44,985
| -64% | -$1.61M |
2017 Q1
8 quarters
|
|
3684
American Coastal Insurance
ACIC
$445M
| $929K | ﹤0.01% |
58,439
-2,610
| -4% | -$42.2K |
2017 Q2
7 quarters
|
|
|
EPZM
3685
PUT
DELISTED
Epizyme, Inc
EPZM
| $929K | ﹤0.01% |
75,000
+40,000
| +114% | +$447K |
2018 Q3
2 quarters
|
|
|
FG
3686
DELISTED
FGL Holdings Ordinary Shares
FG
| $928K | ﹤0.01% |
117,967
-48,898
| -29% | -$388K |
2018 Q1
4 quarters
|
|
3687
Camtek
CAMT
$7.21B
| $923K | ﹤0.01% |
103,437
+65,862
| +175% | +$533K |
2018 Q2
3 quarters
|
|
3688
Sturm, Ruger & Co
RGR
$697M
| $921K | ﹤0.01% |
17,378
+7,707
| +80% | +$420K |
2015 Q2
15 quarters
|
|
|
BHBK
3689
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $920K | ﹤0.01% |
38,502
-35,855
| -48% | -$842K |
2017 Q4
5 quarters
|
|
|
NXGN
3690
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $917K | ﹤0.01% |
54,467
-20,012
| -27% | -$347K |
2016 Q4
9 quarters
|
|
3691
State Street SPDR S&P Capital Markets ETF
KCE
$516M
| $916K | ﹤0.01% |
17,215
+797
| +5% | +$41.9K |
2017 Q4
5 quarters
|
|
|
BRG
3692
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $916K | ﹤0.01% |
84,956
+34,518
| +68% | +$360K |
2015 Q2
15 quarters
|
|
3693
CALL
Kimco Realty
KIM
$14.9B
| $914K | ﹤0.01% |
+49,400
| New | +$848K |
2019 Q1
0 quarters
|
|
|
3694
PUT
Kimco Realty
KIM
$14.9B
| $914K | ﹤0.01% |
+49,400
| New | +$848K |
2019 Q1
0 quarters
|
|
|
CBPO
3695
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $913K | ﹤0.01% |
+10,000
| New | +$818K |
2019 Q1
0 quarters
|
|
3696
CALL
Alkermes
ALKS
$6.99B
| $912K | ﹤0.01% |
+25,000
| New | +$826K |
2019 Q1
0 quarters
|
|
|
NCSM
3697
DELISTED
NCS Multistage Holdings
NCSM
| $912K | ﹤0.01% |
8,805
+2,436
| +38% | +$270K |
2017 Q3
6 quarters
|
|
3698
Viridian Therapeutics
VRDN
$2.06B
| $909K | ﹤0.01% |
21,712
-4,429
| -17% | -$200K |
2017 Q3
6 quarters
|
|
|
USAK
3699
DELISTED
USA Truck Inc
USAK
| $907K | ﹤0.01% |
62,756
+60,733
| +3,002% | +$1.03M |
2017 Q3
6 quarters
|
|
3700
JELD-WEN Holding
JELD
$158M
| $905K | ﹤0.01% |
51,242
+30,564
| +148% | +$550K |
2017 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.